Leaps by Bayer is a corporate impact investment leader, tackling 10 of humanity’s biggest challenges through life science innovations. With over $1.9 billion invested in 60+ companies, they’re reshaping sustainable proteins, agriculture’s footprint, cancer cures, & more. Christine was invited by their leadership to curate an exclusive investor dinner during the World AgriTech Investment Summit in London. She designed a captivating program, selecting distinguished speakers, and leading a fireside chat with the UK’s ARIA program director on Programmable Plants—covering advances like synthetic chromosomes and cross-species chloroplasts. Christine worked with the Leaps team to add thoughtful, sustainable details like custom-made edible centrepieces and a nutritious, sustainable menu. Her efforts led to meaningful connections with new investors, directly supporting Leaps’ mission to fuel groundbreaking innovation.